Boston Scientific Corp. (NYSE:BSX)
| CAPS Rating |
|
|---|---|
| Open | $5.91 |
| Previous Close | $5.95 |
| Daily Range | $5.84 - $5.97 |
| 52-Week Range | $5.01 - $7.96 |
| Market Cap | $9.08B |
| P/E Ratio | 13.90 |
| Dividend (Yield) | N/A (N/A) |
| Volume | 7,653,086 |
| Average Daily Volume | 0 |
How do you think BSX will perform against the market?
Caps
Motley Fool CAPS is a community working together to find better stocks and to become better investors.
BSX Advanced Details
- CAPS Community Analysis: Commentary, Scorecard
- Advanced Financial Analysis: Historical Prices, Chart, Stats, Ratios, Earnings/Growth Rates, Statements, SEC Filings
BSX News and Commentary
- 1 Reason Boston Scientific Looks Attractive – The Motley Fool
- Two Comeback Corporate Bonds – Minyanville
- Earnings Scorecard: St. Jude - Analyst Blog – NASDAQ
- The Zacks Analyst Blog Highlights: Medtronic, Edwards Lifesciences, Boston Scientific, St Jude Medic – NASDAQ
- AngioDynamics to Buy Navilyst - Analyst Blog – NASDAQ
- Positive Outcome on MDT's CoreValve - Analyst Blog – NASDAQ
- BSX Disappoints, Guidance Weak - Ahead of Wall Street – NASDAQ
- Fool Cheat Sheet: Boston Scientific Earnings – The Motley Fool
- UPDATE: Boston Scientific 4Q Net Down 55% As Cardiac Rhythm Sales Fall – SmartMoney
- Boston Scientific 4Q Net Down 55% As Cardiac Rhythm Sales Fall – SmartMoney
- Bard Tops in 4Q, Charges Crimp Net - Analyst Blog – NASDAQ
- Earnings Preview: C.R. Bard - Analyst Blog – NASDAQ
- Earnings Preview: Boston Scientific - Analyst Blog – NASDAQ
- AngioDynamics Cuts View on Recall - Analyst Blog – NASDAQ
- The Zacks Analyst Blog Highlights: Medtronic, Edwards Lifesciences, Boston Scientific, St Jude Medic – NASDAQ
- MDT Advances in CoreValve US Trial - Analyst Blog – NASDAQ
- St. Jude Beats, Charges Hurt Net - Analyst Blog – NASDAQ
- Stryker Meets in 4Q, Profit Jumps - Analyst Blog – NASDAQ
- Earnings Preview: St. Jude - Analyst Blog – NASDAQ
- Has Medtronic Become the Perfect Stock? – The Motley Fool

RSS Headlines
Fool UK